03:47 PM EST - Kane Biotech Inc. : announced it has received Notification Number "NN.XZ5M" from the Interim Notification Program for Low Risk Veterinary Health Products (LRVHP) for the Company's first dermatological formulation (under the brand name DispersinB). DispersinB Topical Spray is a unique antibiofilm-antimicrobial and non-antibiotic formulation that can be applied to the skin and coat of dogs and horses. Kane Biotech Inc.
shares V.KNE are trading up $0.005 at $0.10.
